Essex Woodlands Management, Inc. Long-Term Concentrated

CIK: 0001542339 · Show all filings

Period: Q4 2016 (← Previous) (Next →)

Filing Date: Mar 7, 2017

Total Value ($000): $438,479 (100.0% shares, 0.0% debt)

Holdings (10)

— ABIOMED INC 37.3%

Value ($000) $163,386 Shares 1,450,000 Est. Cost $21.56 Unrealized —

— REVANCE THERAPEUTICS INC 21.7%

Value ($000) $95,055 Shares 4,592,047 Est. Cost $31.50 Unrealized —

— ENTELLUS MEDICAL INC 16.5%

Value ($000) $72,336 Shares 3,813,197 Est. Cost $21.90 Unrealized —

AXGN AXOGEN INC 10.0%

Value ($000) $43,750 Shares 4,861,111 Est. Cost $4.01 Unrealized +115.0%

— CORIUM 8.7%

Value ($000) $37,974 Shares 9,353,304 Est. Cost $7.77 Unrealized —

— ENDOLOGIX INC 3.2%

Value ($000) $14,217 Shares 1,257,468 Est. Cost $18.00 Unrealized —

MNOV MEDICINOVA INC 1.6%

Value ($000) $7,057 Shares 1,170,370 Est. Cost $2.95 Unrealized +138.8%

LGND LIGAND 0.6%

Value ($000) $2,420 Shares 32,893 Est. Cost $74.21 Unrealized -15.0%

ACUR ACURA PHARMACEUTICALS INC 0.3%

Value ($000) $1,506 Shares 1,956,397 Est. Cost $3.40 Unrealized -69.3%

— CATALYST 0.2%

Value ($000) $778 Shares 1,179,352 Est. Cost $4.80 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
—	ABIOMED INC	1,450,000	$163,386	37.3%	$21.56	—	COM	003654100
—	REVANCE THERAPEUTICS INC	4,592,047	$95,055	21.7%	$31.50	—	COM	761330109
—	ENTELLUS MEDICAL INC	3,813,197	$72,336	16.5%	$21.90	—	COM	29363K105
AXGN	AXOGEN INC	4,861,111	$43,750	10.0%	$4.01	+115.0%	COM	05463X106
—	CORIUM	9,353,304	$37,974	8.7%	$7.77	—	COM	21887L107
—	ENDOLOGIX INC	1,257,468	$14,217	3.2%	$18.00	—	COM	29266S106
MNOV	MEDICINOVA INC	1,170,370	$7,057	1.6%	$2.95	+138.8%	COM	58468P206
LGND	LIGAND	32,893	$2,420	0.6%	$74.21	-15.0%	COM	53220K504
ACUR	ACURA PHARMACEUTICALS INC	1,956,397	$1,506	0.3%	$3.40	-69.3%	COM	00509L802
—	CATALYST	1,179,352	$778	0.2%	$4.80	—	COM	14888D109